Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

By afschroeder • May 20, 2026

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for cefixime susceptibility in Neisseria gonorrhoeae. mSphere. 2026 May 19:e0018226. doi: 10.1128/msphere.00182-26. Epub ahead of print. PMID: 42153664.

Tags: antimicrobial resistance, Cas13, cefixime, CRISPR, Infectious Diseases, Neisseria gonorrhoeae, point-of-care, Publications, resistance-guided therapy

Implementation strategies to increase Malawian health care workers’ knowledge about and self-efficacy to recommend HPV vaccination: A pilot study

Moucheraud C, Phiri S, Phiri K, Kalande P, Makwaya A, Kamtsendero L, Chimbaka H, Gürpınar NG, Hagstrom C, van Oosterhout JJ, Szilagyi PG, Guastaferro K,[...]

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19

Kung E, Deo R, Choudhary MC, Chew KW, Evering TH, Ignacio RB, Jagannathan P, Flynn JP, Regan J, Moser C, Giganti MJ, Hughes MD, Ritz[...]

Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution

Edelstein GE, Sass TN, Deo R, Glover OT, Boucau J, Jaganathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Javan AC, Fletcher CV, McCarthy[...]